Biochem/physiol Actions
VX-702 is a second generation p38α MAPK inhibitor with 14-fold higher potency against p38α versus p38β.
- UPC:
- 12352200
- Condition:
- New
- Availability:
- 3-5 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- MPN:
- SML2493-25MG
- CAS:
- 745833-23-2